Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Selecta, JDRF and Sanofi to develop a synthetic vaccine particle immunotherapy for type 1 diabetes

Oct. 17, 2014

Alexion submits NDA in Japan for asfotase alfa

Oct. 16, 2014

Beta cell-specific insulin gene knockout model reveals pancreatic cell fate in diabetes

Oct. 16, 2014

Researchers at Roche present novel A-FABP inhibitors

Oct. 15, 2014

Alnylam presents data from phase II extension study of patisiran in FAP

Oct. 14, 2014

Xoma initiates phase I trial of insulin receptor inhibitor antibody

Oct. 10, 2014

Boston Therapeutics reports topline phase IIb data for BTI-320 in type 2 diabetes

Oct. 10, 2014

Novel DPP IV inhibitor discovered for the treatment of type 2 diabetes

Oct. 10, 2014

Novel PDH kinase inhibitors patented at Japan Tobacco

Oct. 10, 2014

Promising initial phase I data for pramlintide/insulin fixed-dose combination

Oct. 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...